Serum lactate dehydrogenase level in preeclampsia and its correlation with disease severity, maternal and perinatal outcomes

Abstract Background Preeclampsia is a rapidly progressing pregnancy-specific multi-systemic syndrome that is the leading cause of maternal and neonatal morbidity and mortality. Lactate dehydrogenase (LDH) is a valuable and potential biomarker for predicting the severity of Preeclampsia. Objectives T...

Full description

Saved in:
Bibliographic Details
Main Authors: Sallama Kamel Nasir, Rozhan Yassin Khalil, Maryam Bakir Mahmood, Aveen Saadi Dawd
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Women's Health
Subjects:
Online Access:https://doi.org/10.1186/s12905-025-03622-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850039475022856192
author Sallama Kamel Nasir
Rozhan Yassin Khalil
Maryam Bakir Mahmood
Aveen Saadi Dawd
author_facet Sallama Kamel Nasir
Rozhan Yassin Khalil
Maryam Bakir Mahmood
Aveen Saadi Dawd
author_sort Sallama Kamel Nasir
collection DOAJ
description Abstract Background Preeclampsia is a rapidly progressing pregnancy-specific multi-systemic syndrome that is the leading cause of maternal and neonatal morbidity and mortality. Lactate dehydrogenase (LDH) is a valuable and potential biomarker for predicting the severity of Preeclampsia. Objectives To assess the level of LDH in women with preeclampsia and to correlate its level with the severity of the disease and maternal/perinatal outcomes. Patients and methods This prospective case-control study was conducted at Sulaimani Maternity Teaching Hospital, Sulaimaniyah, Iraq, from March 1st, 2021, to June 30th, 2022, on 150 pregnant women in 3rd trimester of their pregnancy. Patients (n = 100) were diagnosed with mild and severe Preeclampsia. Serum LDH level was measured and correlated with the severity of the disease and maternal/perinatal outcomes. Results LDH was significantly (p = 0.001) elevated in preeclampsia groups compared to the control group. The mild preeclampsia group had a mean LDH level of 302.9 ± 138.5 IU/L, while the severe preeclampsia group had a mean level of 488.6 ± 223.4 IU/L. Also, maternal complications, stillbirth rate, and neonatal intensive Care Unit (NICU) admission were higher in women with high LDH levels. Conclusions The serum LDH level is high in women with preeclampsia and correlated with the disease severity as well as maternal and perinatal outcomes. So, serum LDH may be a valuable biomarker for predicting the severity of preeclampsia.
format Article
id doaj-art-384072ec12de4631bcff03ac2cb64a96
institution DOAJ
issn 1472-6874
language English
publishDate 2025-03-01
publisher BMC
record_format Article
series BMC Women's Health
spelling doaj-art-384072ec12de4631bcff03ac2cb64a962025-08-20T02:56:20ZengBMCBMC Women's Health1472-68742025-03-012511710.1186/s12905-025-03622-5Serum lactate dehydrogenase level in preeclampsia and its correlation with disease severity, maternal and perinatal outcomesSallama Kamel Nasir0Rozhan Yassin Khalil1Maryam Bakir Mahmood2Aveen Saadi Dawd3Department of Clinical Medical Sciences, College of Medicine, University of SulaimaniDepartment of Clinical Medical Sciences, College of Medicine, University of SulaimaniDepartment of Clinical Medical Sciences, College of Medicine, University of SulaimaniSulaimani Maternity Teaching Hospital, Sulaimani Directorate of HealthAbstract Background Preeclampsia is a rapidly progressing pregnancy-specific multi-systemic syndrome that is the leading cause of maternal and neonatal morbidity and mortality. Lactate dehydrogenase (LDH) is a valuable and potential biomarker for predicting the severity of Preeclampsia. Objectives To assess the level of LDH in women with preeclampsia and to correlate its level with the severity of the disease and maternal/perinatal outcomes. Patients and methods This prospective case-control study was conducted at Sulaimani Maternity Teaching Hospital, Sulaimaniyah, Iraq, from March 1st, 2021, to June 30th, 2022, on 150 pregnant women in 3rd trimester of their pregnancy. Patients (n = 100) were diagnosed with mild and severe Preeclampsia. Serum LDH level was measured and correlated with the severity of the disease and maternal/perinatal outcomes. Results LDH was significantly (p = 0.001) elevated in preeclampsia groups compared to the control group. The mild preeclampsia group had a mean LDH level of 302.9 ± 138.5 IU/L, while the severe preeclampsia group had a mean level of 488.6 ± 223.4 IU/L. Also, maternal complications, stillbirth rate, and neonatal intensive Care Unit (NICU) admission were higher in women with high LDH levels. Conclusions The serum LDH level is high in women with preeclampsia and correlated with the disease severity as well as maternal and perinatal outcomes. So, serum LDH may be a valuable biomarker for predicting the severity of preeclampsia.https://doi.org/10.1186/s12905-025-03622-5PreeclampsiaSerum lactate dehydrogenaseDisease severityMaternal/perinatal outcomes
spellingShingle Sallama Kamel Nasir
Rozhan Yassin Khalil
Maryam Bakir Mahmood
Aveen Saadi Dawd
Serum lactate dehydrogenase level in preeclampsia and its correlation with disease severity, maternal and perinatal outcomes
BMC Women's Health
Preeclampsia
Serum lactate dehydrogenase
Disease severity
Maternal/perinatal outcomes
title Serum lactate dehydrogenase level in preeclampsia and its correlation with disease severity, maternal and perinatal outcomes
title_full Serum lactate dehydrogenase level in preeclampsia and its correlation with disease severity, maternal and perinatal outcomes
title_fullStr Serum lactate dehydrogenase level in preeclampsia and its correlation with disease severity, maternal and perinatal outcomes
title_full_unstemmed Serum lactate dehydrogenase level in preeclampsia and its correlation with disease severity, maternal and perinatal outcomes
title_short Serum lactate dehydrogenase level in preeclampsia and its correlation with disease severity, maternal and perinatal outcomes
title_sort serum lactate dehydrogenase level in preeclampsia and its correlation with disease severity maternal and perinatal outcomes
topic Preeclampsia
Serum lactate dehydrogenase
Disease severity
Maternal/perinatal outcomes
url https://doi.org/10.1186/s12905-025-03622-5
work_keys_str_mv AT sallamakamelnasir serumlactatedehydrogenaselevelinpreeclampsiaanditscorrelationwithdiseaseseveritymaternalandperinataloutcomes
AT rozhanyassinkhalil serumlactatedehydrogenaselevelinpreeclampsiaanditscorrelationwithdiseaseseveritymaternalandperinataloutcomes
AT maryambakirmahmood serumlactatedehydrogenaselevelinpreeclampsiaanditscorrelationwithdiseaseseveritymaternalandperinataloutcomes
AT aveensaadidawd serumlactatedehydrogenaselevelinpreeclampsiaanditscorrelationwithdiseaseseveritymaternalandperinataloutcomes